Thor Medical ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Selling, General & Admin	21.89	13.29	3.14	-
Other Operating Expenses	30.06	28.26	3.69	-
Operating Expenses	64.13	43.93	7.16	-
Operating Income	-64.03	-43.93	-7.16	-
Interest Expense	-0.2	-0.1	-	-
Interest & Investment Income	1.75	1.45	2.02	-
Currency Exchange Gain (Loss)	1.14	-0.06	-0.25	-
Other Non Operating Income (Expenses)	-0.09	0.01	-0.17	-
Pretax Income	-61.44	-42.64	-5.56	-
Income Tax Expense	-2.53	-0.43	-	-
Earnings From Continuing Operations	-58.91	-42.21	-5.56	-
Earnings From Discontinued Operations	-	-	-21	-311.24
Net Income	-58.91	-42.21	-26.56	-311.24
Net Income to Common	-58.91	-42.21	-26.56	-311.24
Shares Outstanding (Basic)	274	236	175	115
Shares Outstanding (Diluted)	274	236	175	115
Shares Change (YoY)	17.08%	34.90%	51.82%	-
EPS (Basic)	-0.22	-0.18	-0.15	-2.70
EPS (Diluted)	-0.22	-0.18	-0.15	-2.70
Free Cash Flow	-74.22	-24.12	-64.09	-414.71
Free Cash Flow Per Share	-0.27	-0.10	-0.37	-3.60
EBITDA	-51.85	-41.55	-6.83	-
D&A For EBITDA	12.18	2.38	0.33	-
EBIT	-64.03	-43.93	-7.16	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.